Roivant Sciences (ROIV) Inventory (2023 - 2024)
Roivant Sciences' (ROIV) quarterly Inventory came in at $34.0 million in Q2 2024, up 704.66% YoY from $4.2 million in Q3 2023, and down 3.56% on a QoQ basis from $35.3 million in Q1 2024.
Powered by 
Analysis
Roivant Sciences (ROIV) Inventory (2023 - 2024) Analysis & Trends
Roivant Sciences (ROIV) has 2 years of Inventory data on file, last reported at $34.0 million in Q2 2024.
- Quarterly Inventory rose 704.66% year-over-year to $34.0 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $34.0 million (up 704.66% YoY) and the FY2024 annual result came in at $35.3 million, up 1176.75% from the prior year.
- Inventory fell to $34.0 million in Q2 2024, from $35.3 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $35.3 million in Q1 2024 to a low of $2.8 million in Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 280.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 732.60 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 97.11 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Roivant Sciences | 25.18 Bn | 25.18 Bn | 1.16 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 34.00 Mn |
| Mar 31, 2024 | 35.25 Mn |
| Dec 31, 2023 | 5.24 Mn |
| Sep 30, 2023 | 4.91 Mn |
| Jun 30, 2023 | 4.23 Mn |
| Mar 31, 2023 | 2.76 Mn |